| |
Citation: George PDC, Dike IP, Rao S (2008) Application of Computational Tools for Identification of miRNA
and Their Target SNPs. J Proteomics Bioinform 1: 359-367.
|
Copyright: © 2008 George PDC, etal. This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original
author and source are credited.
|
Abstract
MicroRNAs (miRNAs) are a class of small non-protein-coding RNAs that play important regulatory roles by
targeting for cleavage or translational repression and involved in diverse biological functions. Accumulation of
large amount of biological data indicates that miRNAs can function as tumor suppressors and oncogenes. Mutation,
misexpression, and altered mature miRNA processing are implicated in carcinogenesis and tumor progression.
Common single-nucleotide polymorphisms (SNPs) in miRNAs may change their property through altering
miRNA expression and/or maturation, and thus they may have an effect on thousands of target mRNAs, resulting
in diverse functional consequences. In this work we used computational tools to predict the functional role of
mRNAs targeted by miRNA in colon cancer genes. We have presented a method which allows the use of PupaSuite,
UTRscan and miRBase as a pipeline for the prediction of miRNA and their target, and evaluated the functional
role of mRNA in colon cancer.
Keywords
miRNA; SNPs; miRBase; PupaSiute; UTRscan
Introduction
Identifying the genes and mutations underlying
phenotypic variation is one of the primary objectives of
modern genetics, especially for traits of medical importance.
Over the past decades, studies have analyzed and
unveiled the genetic variants in the human genome, such
as single-nucleotide polymorphisms (SNPs) (Stranger et
al., 2007) which contribute to gene expression variation,
and eventually to phenotypic variation in human populations
(Rockman and Kruglyak 2006). Single-nucleotide
polymorphisms (SNPs) are the most frequent variation in
the human genome, occurring once every several hundred
base pairs throughout the genome. They have been
studied extensively for defining the regions of disease
candidate genes (Bernig and Chanock 2006). The majority
of SNPs in the genome occur in untranslated, intronic
or intergenic regions. These SNPs could affect complex
diseases through their effect on gene expression quantitatively.
It is increasingly recognized that regulatory mutations
could make a significant contribution to genetic
variation, especially for complex traits, including disease
susceptibility. Recent reports have shown that mutations
in the coding region disrupting sequences recognized by
splicing regulators such ESE or ESS can be considered
an additional mutation mechanism leading to disease in
humans (Pagani et al., 2003). This finding is particularly
important for genetic counseling, where the pathogenicity
assessment of any nucleotide substitution is crucial to
correctly predict cancer risk. Taking in to this account, our group recently published a review on the use of computational
tools to identify deleterious SNPs in both coding
and noncoding regions taking TP53 as a pipeline gene
(George et al., 2008).
MicroRNAs (miRNAs) are small 21-25 nucleotide
non-protein-coding RNAs that comprise an evolutionarily
conserved class of ribo-regulators which modulate
gene expression via the RNA interference pathway
(Ambros V 2004). miRNAs are thought to regulate gene
expression post-transcriptionally by forming Watson-Crick
base pairs with target mRNAs. miRNAs use two distinct
post-transcriptional mechanisms to down-regulate gene
expression. They act by binding to the complementary
sites on the 3' untranslated region (UTR) of the target
gene to induce cleavage with near perfect complementarity
or to repress productive translation (Brennecke et al., 2005)
and also facilitate deadenylation, which leads to rapid
mRNA decay (Wu et al., 2006). Accumulation of large
amount of biological data suggests that a single miRNA could
bind to hundreds of mRNA targets, and these targets could
be implicated in the regulation of almost every biological
process (Zamore et al., 2005). miRNAs assert their function
as oncogenes or tumor suppressor genes via several
potential mechanisms in various forms of cancers (Calin et
al., 2002; Cimmino et al., 2005; Borkhardt et al, 2006). Literature
survey shows that miRNAs are also involved in solid
tumors such as lung cancer, breast cancer and colorectal
cancer (CRC) (Iorio et al, 2005; Karube et al, 2005; Michael
MZ et al, 2003). Loss or amplification of miRNA genes has
been reported in a variety of cancers, and altered patterns
of miRNA expression may affect cell cycle and survival
programs (Yanaihara et al., 2006).
|
Figure 1: Flow-chart of the proposed methodology for the prediction of miRNA and their targets. |
Because small variation in the quantity of miRNAs may have an effect on thousands of target mRNAs and result in diverse functional con-sequences, the most common genetic variation, SNPs, in
miRNA sequences may also be functional and therefore
may represent ideal candidate biomarkers for cancer prognosis.
In recent years, few studies have described role of
naturally occurring human polymorphisms associated with
miRNAs and their target sites (Iwai et al., 2005; Chen et
al., 2006). Clop et al 2006 stated that the SNP may affect
organismal phenotype by altering a miRNA target site, leading
to a significant alteration of protein expression. Given
the wealth of data that is currently available in databases
for human SNPs, such as the human genome variation
database, HGVBase (Fredman et al., 2002) and the National
Center for Biotechnology Information (NCBI) database,
dbSNP (Smigielski et al., 2000), we can begin to identify
naturally occurring variation associated with miRNAs
and their targets using an in silico approach. SNPs in critical
components of the miRNA system may have important
phenotypic consequences, with implications for both evolutionary
studies and biomedical research. In this study, we
conducted a bioinformatics genome-wide survey on genes
causing colon cancer and identified miRNA and their target
mRNA using computational algorithims like PupaSuite
(Reumers et al., 2008) which uses miRanda (John et al.,
2005) and miRBase (Griffiths-jones et al., 2008). We
searched for SNPs that would potentially affect novel target
sites in humans and speculate that some of these variations
may have functional effects using UTRscan and
PupaSuite. These methods are based on different principles
and merging them into a pipeline for predicting the function
of target mRNA is therefore meaningful. Flow-chart of
the proposed methodology is depicted in Figure 1.
Materials and Methods
Searching of gene ids and their single nucleotide polymorphisms
A total of 20 genes responsible for causing colon cancer
(Familial adenomatous polyposis and Lynch syndrome) as
shown in Table 1 were collected from OMIM and HGMD
and submitted to PupaSuite to extract miRNA and their
target mRNA. Based on the results obtained from
PupaSuite, we retrieved the information for UTR SNPs of
the genes namely APC, AXIN2, CTNNB1, MAP2K4,
MLH1, MSH2, MSH3, MYH, TP53 and STK11 from the
Human genome variation database, HGVBase and National
Center for Biotechnology Information (NCBI) database,
dbSNP for our computational analysis.
Scanning for miRNA and their target sites
PupaSuite is a unique and more integrated interface of
PupaSNP (Conde et al., 2004) and PupasView (Conde et
al., 2005) are now synchronized to deliver annotations for
both noncoding and coding SNP, as well as annotations for the SwissProt set of human disease mutations. In this approach,
the input consists of a list of genes (genes belonging
to a given pathway, involved in a particular biological
function, etc.) and the user must specify the type of gene
identifiers by selecting either Ensembl or an external database
(which include GenBank, Swissprot/TrEMBL and other
gene ids supported by Ensembl). Pupasuite retrieves SNPs
that could affect conserved regions that the cellular machinery
uses for the correct processing of genes (intron/
exon boundaries or exonic splicing enhancers) and uses
miRanda an algorithm for the detection of potential
microRNA target sites in genomic sequences.
Analyzing miRNA and their target sites
For the detection of potential microRNA target sites in
genomic sequences, we applied miRBase to validate our prediction. miRBase scans one or more miRNA sequences
against all sequences and potential target sites are reported.
Table 1: List of genes responsible for causing colon cancer. |
A dynamic programming local alignment is carried out between
the query miRNA sequence and the reference sequence.
The alignment procedure scores are based on sequence
complementarity between A:U and G:C matches
and not on sequence identity. Then, it takes the high-scoring
alignments of those above as a score threshold, detected
from local alignment and estimates the thermodynamic stability
of RNA duplexes based on these alignments. For this
method, miRanda utilizes folding routines from the RNAlib
library, which is part of the ViennaRNA (Wuchty et al.,
1999). The free energy (ÄG) of optimal strand-strand interaction
between miRNA and UTR is computed by the Vienna RNA folding routines and is a measure for the thermodynamic
stability of a duplex. P-values for all target sites
were calculated in miRinda based on the model proposed
by Rehmsmeier M et al., 2004. Base P-value is computed
using distribution parameters derived from the genomic background
of miRanda scores.
Scanning of noncoding SNPs
Functional significance of each SNP in untranslated
region (UTR) was determined by UTRscan (Pesole et al.,
1999) available at (http://www.ba.itb.cnr.it/BIG/UTRScan).
UTResource, which is an internet resource of sequence
analysis of 5’ and 3’ UTR of eukaryotic mRNAs which are
involved in many posttranscriptional regulatory pathways
that control mRNA localization, stability, and translation efficiency
(Sonenberg 1994; Nowak 1994). Briefly, two or
three sequences of each UTR SNP that have a different
nucleotide at an SNP position were analyzed by UTRscan,
which looks for UTR functional elements by searching
through user-submitted sequence data for the patterns defined
in the UTR site and UTR databases. If different sequences
for each UTR SNP are found to have different
functional patterns, this UTR SNP is predicted to have functional
significance. The internet resources for UTR analysis
were UTRdb and UTRsite. UTRdb contains experimentally
proven biological activity of functional patterns of UTR
sequence from eukaryotic mRNAs (Pesole et al., 2002).
The UTRsite has the data collected from UTRdb and also
is continuously enriched with new functional patterns.
Results
Prediction of miRNA and their Target Sites
Among the 20 genes which were submitted to PupaSuite,
only 10 genes (50%) displayed miRNA and their targets.
Pupasuite scans the whole genome to find SNPs located at
miRNAs. PupaSuite uses miRanda an algorithm for the
detection of potential microRNA target sites in genomic
sequences. Four miRNAs namely hsa-miR-663, hsa-miR-
328, hsa-miR-325 showed a target mRNA SNP rs10415095
and two miRNAs namely hsa-miR-638 and hsa-miR-572
showed a target mRNA SNP rs11552326 in STK11 gene,
two miRNAs namely hsa-miR-637 and hsa-miR-557 showed
a target mRNA SNP rs35352891 and two miRNAs namely
hsa-miR-539 and hsa-miR-431 showed a target mRNA SNP
rs3219496 in MYH gene, two miRNAs namely hsa-miR-
545 and hsa-miR-135b showed one target mRNA SNP
rs17225060 in MSH2 gene, three miRNAs namely hsa-miR-
302c, hsa-miR-372 and hsa-miR-512-3p showed one target
mRNA SNP rs1803985 in MLH1 gene and two miRNAs
namely hsa-miR-522 and hsa-miR-642 showed one target
mRNA SNP in APC gene as shown in Table 2. PupaSiute
uses miRanda, an algorithm for the detection of potential microRNA target sites in genomic sequences, to localize all
the SNPs situated in the region 3’ UTR of these targets
sites. miRanda calculated the scores based on the
complementarity of nucleotides (A=U or G=C) and G=U
wobble pairs, which are important for the accurate detection
of RNA:RNA duplexes. The result is a score (S) for
each detected complementarity match between a miRNA
and a potential target gene and range is between 15.1679 to
19.0061. The minimum free energy (MFE) of the miRNA–
target duplex was determined while predicting the miRNA
target sites. The lower MFE values of the miRNAs and the
target sites reveal the energetically more probable hybridizations
between the miRNAs and the target genes. It can
be seen from Table 1 that miRNAs predicted by PupaSuite
exhibited a low minimum free energy range from -10.09 to
-34.79. It is an important noteworthy finding in miRNA and
their target mRNAs analysis using PupaSuite. Recent publications
suggest that multiple potential binding sites of a
miRNA in a single target are good evidence for the target
being regulated by the miRNA. If we consider a potential
binding site being a rare event in our random model, the
number of binding sites can be approximated by a Poisson
distribution (Hofacker et al., 1994). The provision of P-value
and Base P-value for the miRNA allows the users to assess
the confidence in the prediction. Based on the above
observations depicted in Table 2 the miRNAs namely hsamiR-
622, hsa-miR-641, hsa-miR-560, hsa-miR-611, hsamiR-
637, hsa-miR-557, hsa-miR-663, hsa-miR-572, hsamiR-
560 and hsa-miR-638 predicted by PupaSuite by our
investigation is also well documented by on experimental
protocols (Bandres et al., 2006; Cummins et al., 2006). This
is an important result from this work.
Predictions of potential phenotypic effect in SNPs
We further analyzed the miRNA targets and predicted
the role of mRNA SNPs using PupaSuite. Besides indispensable
cis regulatory motifs such as 5’ and 3’ splice sites
and branch points, there are other cis regulatory sequences
called exonic or intronic splicing enhancers and silencers
(Fu 2004). These sequences are recognized by a number of
regulatory proteins, represented, for example, by serine/arginine-
rich (SR) proteins, which bind RNA with limited sequence
specificity (Liu et al., 1998). ESEs are common in
alternative and constitutive exons, where they act as binding
sites for Ser/Arg-rich proteins (SR proteins), a family of
conserved splicing factors that participate in multiple steps
of the splicing pathway (Graveley 2000). ESSs are sequence
elements that are known to regulate alternative splicing and
also play a role in splice site selection (Fairbrother and Chasin
2000).
Table 2: miRNA and their target mRNA in colon cancer. |
As a result of premRNA splicing, different combinations
of exons may arise and may be a ‘natural’ cause of errors in gene expression by introducing premature termination
codons or altering protein structure leading to changes
in spectrum of interacting proteins, intracellular localization,
protein stability or posttranslational modification (Stamm et
al., 2005). Seven SNPs rs397768, rs10438779, rs1722851,
rs1049443, rs36053993, rs1794293 and rs10415095 with ids
were predicted to disrupt the exonic splicing enhancers and
three SNPs rs1803985, rs3219496 and rs11552326 with ids
were predicted to disrupt the exonic splicing silencers by
PupaSuite.
Discussion
A revolution is underway in the approach to studying the
genetic basis of cancer. In the past, most studies have focused
on protein coding genes and their regulation at the
transcriptional level. The recent explosion of miRNA research
and discovery further underscores the importance
of these regulatory molecules in many key biological processes,
such as development, cellular differentiation, cell
cycle control and apoptosis. Polymorphisms and mutations
in the corresponding sequence space (machinery, miRNA
precursors and target sites) are likely to make a significant
contribution to phenotypic variation, including disease susceptibility.
The mutations in miRNAs or polymorphisms in
the mRNAs targeted by miRNAs may also contribute to
cancer predisposition and progression (Saunders MA et al.,
2007). Their expression profiles can be used for the classification,
diagnosis, and prognosis of human malignancies.
Most of the mutations identified till date lead to alter in primary
sequence and hence alter in protein structure (missense
or nonsense, insertion–deletions in the open reading
frame, or mutations causing splicing errors). Recent studies
show that regulatory mutations could make a significant
contribution to genetic variation, including disease susceptibility
lead to the identification of the mutations in regulatory
variants (rSNPs) affecting transcript levels in cis (Pastinen
et al., 2006). The most common interpretation of such cis
effects is that the corresponding variants are modulating
the activity of regulatory elements, including promotors and
enhancers.
We applied computational tools like PupaSuite, miRBase
and UTRscan to validate miRNA and their targets using
colon cancer genes. PupaSuite uses miRanda algorithm for
the identification of miRNAs and their target mRNA. Out
of twenty genes retrieved from OMIM causing colon cancer,
PupaSuite predicted miRNA and their target mRNA
for only ten genes (50%). A total of thirty miRNAs and
mRNAs were obtained from PuaSuite for further analysis.
Of those predicted target genes in causing colon cancer
(Table 2), miRNAs in genes namely APC, MLH1, MSH2,
MYH and STK11 had more than one predicted target interaction
site. These results suggest that 3' UTRs with more than one predicted target site for a given miRNA are more
reliable than those with a single site. This concept of multiple
miRNAs binding sites with target mRNA is well supported
by experimental analysis in drosophila (Enright et al.,
2003). Out of the predicted thirty miRNAs, ten miRNAs
(33%) namely hsa-miR-622, hsa-miR-641, hsa-miR-560,
hsa-miR-611, hsa-miR-637, hsa-miR-557, hsa-miR-663, hsamiR-
572, hsa-miR-560 and hsa-miR-638 predicted by
PupaSuite by our investigation is also well documented by
on experimental protocols (Bandres et al., 2006; Cummins
et al., 2006). Functional role of target mRNA SNPs were
validated using PuaSuite and UTRscan. In-silico methods
provide a useful tool for an initial approach to any mutation
suspected of causing aberrant RNA processing. These mutations
can result in either complete skipping of the exon,
retention of the intron or the introduction of a new splice
site within an exon or intron. In rare cases, mutations that
do not disrupt or create a splice site, activate preexisting
pseudo splice sites consistent with the proposal that introns
contain splicing inhibitory sequences (Baralle et al., 2005).
Recent studies showed that the mutations in cis splicing
regulating sequences, which might shift production to mRNA
with cancer-prone potential (Scholzova et al., 2007). Yang
Y et al. 2003 showed, however, that this mutation disrupts
an exonic splicing enhancer and leads to production of null
protein due to aberrant splicing. Among the twenty one targeted
SNPs by miRNAs, seven SNPs (38%) rs397768,
rs10438779, rs1722851, rs1049443, rs36053993, rs1794293
and rs10415095 with ids were predicted to disrupt the exonic
splicing enhancers and three SNPs rs1803985,
rs3219496 and rs11552326 with ids were predicted to disrupt
the exonic splicing silencers, whereas thirteen SNPs
(62%) showed no functional significance by PupaSuite.
Varied levels of alternative splicing have been detected for
some of the splicing mutations in colon cancer genes
(Lastella et al., 2006; Ivan et al., 2003). By UTRscan, six
SNPs (29%) showed a functional pattern change 15-LOXDICE.
Founding members of miRNAs were discovered by
genetic screening approaches, experimental approaches
were limited by their low efficiency, time consuming, and
high cost. As a consequence, several web-based or nonweb-
based computer software programs are publicly available
for predicting miRNAs and their targets have been
devised in order to predict targets for follow up experimental
validation. Even though many computational methods for
the identification of miRNA may have its own limitations,
but there is no other option now other than to use computational
methods for miRNA predictions. The next step in
miRNA research is to identify and experimentally validate
their mRNA targets. Since direct experimental methods for discovering miRNA targets are lacking, a large number of
target prediction algorithms have been developed. Our results
from this study suggests that the application of computational
algorithms, PupaSuite and UTRscan analysis might
provide an alternative approach to select target SNPs by
understanding the effect of SNPs on the functional attributes
or molecular phenotype of a protein. Our result also endorses
a study with an in vivo experimental protocol. Studies
using SNPs to probe the genetic basis of human disease
can provide insights into susceptibility to a disease, modification
of the phenotype of a monogenic disease, and response
to pharmacologic treatment. The functional analysis
in this study may be a good model for further research in
genetically inherited disease.
Conclusion
We have presented computational tools for the identification
of miRNA and their target mRNA in colon cancer. We
tried to predict the functional roles of SNPs in mRNA region.
Based on this, we derived at the following conclusions:
Among the twenty genes selected for our analysis,
miRNAs and their target mRNA are exhibited only by ten
genes. Of these, only five genes showed multiple miRNA interactive sites for single mRNA.
Out of thirty targeted SNPs by miRNAs, only seven SNPs
disrupted the exonic splicing enhancers, three SNPs disrupted
the exonic splicing silencers while thirteen SNPs
showed no functional significance.Six SNPs exhibited functional
pattern change of 15-LOX-DICE in un-translated
regions.
We emphasize that our approach in selecting miRNAs
and their target mRNA in colon cancer using computational
tools is of significant importance and the same methodology
could be adapted to other types of cancer genes also. Evaluation
of target mRNA functional role will be a major challenge
of future studies in the field of cancer biomarker research
and other types of disease.
Acknowledgements
The authors thank the management of Vellore Institute of
Technology for providing the facilities to carry out this work.
The authors take this opportunity to thank the reviewers for
their invaluable comments and suggestions to make this
manuscript more readable and meaningful.
Reference
-
Ambros V (2004) The functions of animal microRNAs.
Nature 431:350–355. [ FIND THIS ARTICLE
ONLINE ]
-
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate
R, etal. (2006) Identification by Real-time PCR of 13
mature microRNAs differentially expressed in colorectal
cancer and non-tumoral tissues. Molecular Cancer 5:
29. [ FIND THIS ARTICLE
ONLINE ]
-
Baralle D, Baralle M (2005) Splicing in action: assessing
disease causing sequence Changes. J Med Genet
42: 737-748. [ FIND THIS ARTICLE
ONLINE ]
-
Bernig T, Chanock SJ (2006) Challenges of SNP
genotyping and genetic variation: its future role in diagnosis
and treatment of cancer. Expert Rev Mol Diagn.
6:319–331. [ FIND THIS ARTICLE
ONLINE ]
-
Brennecke J, Stark A, Russell RB, Cohen SM (2005)
Principles of micro- RNA-target recognition. PLOS Biol
3: e85.
-
Borkhardt A, Fuchs U, Tuschl T (2006) MicroRNA in
chronic lymphocytic Leukemia. N Engl J Med 354: 524–
5. [ FIND THIS ARTICLE
ONLINE ]
-
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S,
etal. (2002) Frequent deletions and down-regulation of
micro-RNA genes miR15 and miR16 at 13q14 in chronic
lymphocytic leukemia. Proc Natl Acad Sci 99: 15524–
9. [ FIND THIS ARTICLE
ONLINE ]
-
Chen K, Rajewsky N (2006) Natural selection on human
microRNA binding sites inferred from SNP data.
Nat Genet 38:1452-1456. [ FIND THIS ARTICLE
ONLINE ]
-
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M,
etal. (2005) miR-15 and miR-16 induce apoptosis by
targeting BCL2. Proc Natl Acad Sci 102:13944–9. [ FIND THIS ARTICLE
ONLINE ]
-
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, etal.
(2006) A mutation creating a potential illegitimate
microRNA target site in the myostatin gene affects muscularity
in sheep. Nat Genet 38:813–818. [ FIND THIS ARTICLE
ONLINE ]
-
Conde L, Vaquerizas JM, Santoyo J, Al-Shahrour F, Ruiz-
Llorente S, etal. (2004) PupaSNP Finder: a web tool for
finding SNPs with putative effect at transcriptional level.
Nucleic Acids Res 32: W242–W248.
-
Conde L, Vaquerizas JM, Ferrer CC, Cruz X, Orozco M, etal. (2005) PupasView: a visual tool for selecting
suitable SNPs, with putative pathological effect in genes,
for genotyping purposes. Nucleic Acids Res 33: W501-
W505.
-
Cummins JM, He Y, Leary RJ, Pagliarini R, etal. (2006)
The colorectal microRNAome. Proc Natl Acad Sci U S
A 103:3687-3692. [ FIND THIS ARTICLE
ONLINE ]
-
Deventer SV (2000) Cytokine and cytokine receptor
polymorphisms in infectious Disease, Intensive Care Med
26: S98-S102.
-
Enright AJ, John B, Gaul U, Tuschl T, Sander C, etal.
(2003) MicroRNA targets in Drosophila. Genome Biology
5: R1. [ FIND THIS ARTICLE
ONLINE ]
-
Fairbrother WG, Chasin LA (2000) Human genomic sequences
that inhibit splicing. Mol Cell Biol 20:6816–6825. [ FIND THIS ARTICLE
ONLINE ]
-
Fredman D, Siegfried M, Yuan YP etal. (2002) HGVbase:
a human sequence variation database emphasizing data
quality and a broad spectrum of data sources. Nucleic
Acids Res 30: 387–391. [ FIND THIS ARTICLE
ONLINE ]
-
Fu XD (2004) Towards a splicing code. Cell 119: 736–
738. [ FIND THIS ARTICLE
ONLINE ]
-
George PDC, Sudandiradoss C, Rajasekaran R,
Choudhury P, Sinha P, etal. (2008) Applications of computational
algorithm tools to identify functional SNPs,
Functional and Integrative Genomics 8: 309–316.
-
Graveley BR (2000) Sorting out the complexity of SR
protein functions. RNA 6:1197–1211. [ FIND THIS ARTICLE
ONLINE ]
-
Griffiths JS, Saini HK, Van DS, Enright AJ (2008)
miRBase: tools for microRNA genomics. Nucleic Acids
Res 36: 154-158.
-
Hofacker IL, Fontana W, Stadler PF, Bonhoeffer S,
Tacker M, etal. (1994) Fast Folding and Comparison of
RNA Secondary Structures. Monatshefte f. Chemie 125:
167-188.
-
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R,
etal. (2005) MicroRNA gene expression deregulation in
human breast cancer. Cancer Res 65: 7065–70. [ FIND THIS ARTICLE
ONLINE ]
-
Ivan P, Gorlov, Olga Y, Gorlova, Marsha L, etal. (2003)
Missense Mutations in hMLH1 and hMSH2 Are Associated
with Exonic Splicing Enhancers. Am J Hum Genet
73:1157–1161. [ FIND THIS ARTICLE
ONLINE ]
-
Iwai N, Naraba H (2005) Polymorphisms in premicroRNAs. Biochem Biophys Res Commun 331:1439-
1444. [ FIND THIS ARTICLE
ONLINE ]
-
John B, Enright AJ, Aravin A, Tuschl T, Sander C, etal.
(2005) Human MicroRNA targets, PLoS Biol 3(7): 264.
-
Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y,
etal. (2005) Reduced expression of Dicer associated with
poor prognosis in lung cancer patients. Cancer Sci 96:
111–5. [ FIND THIS ARTICLE
ONLINE ]
-
Lastella P, Surdo NC, Resta N, Guanti G, Stella A (2006)
In silico and in vivo splicing analysis of MLH1 and MSH2
missense mutations shows exon- and tissue-specific
effects. BMC Genomics 7: 243. [ FIND THIS ARTICLE
ONLINE ]
-
Liu HX, Zhang M, Krainer AR (1998) Identification of
functional exonic splicing enhancer motifs recognized
by individual SR proteins. Genes Dev 12: 1998–2012. [ FIND THIS ARTICLE
ONLINE ]
-
Michael MZ, SM OC, Van Holst Pellekaan NG, Young
GP, James RJ (2003) Reduced accumulation of specific
microRNAs in colorectal neoplasia Mol Cancer Res
1882–91.
-
Nowak R (1994) Mining treasures from ‘junk DNA’.
Science 263:608–610. [ FIND THIS ARTICLE
ONLINE ]
-
Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou
A, Doudounakis S, etal. (2003) New type of disease
causing mutations: the example of the composite exonic
regulatory elements of splicing in CFTR exon 12. Hum
Mol Genet 12: 1111-20. [ FIND THIS ARTICLE
ONLINE ]
-
Pastinen T, Ge B, Hudson TJ (2006) Influence of human
genome polymorphism on gene expression. Hum
Mol Genet 15:R9-R16.
-
Pesole G, Liuni S (1999) Internet resources for the functional
analysis of 5’ and 3’ untranslated regions of eukaryotic
mRNA TIG 15:378.
-
Pesole G, Liuni S, Grillo G, Licciulli F, Mignone F, etal.
(2002) UTRdb and UTRsite: specialized databases of
sequences and functional elements of 5’ and 3’
untranslated regions of eukaryotic mRNAs. Nucleic
Acids Res 30:335–340. [ FIND THIS ARTICLE
ONLINE ]
-
Reumers J, Conde L, Medina I, Maurer SS, Durme JV,
etal. (2008) Joint annotation of coding and non-coding
single nucleotide polymorphisms and mutations in the
SNPeffect and PupaSuite databases, Nucleic Acids Research
36: D825–D829.
-
Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R
(2004) Fast and effective prediction of microRNA/target
duplexes, RNA 10: 1507-1517.
-
Rockman MV, Kruglyak L (2006) Genetics of global
gene expression. Nat Rev Genet 7: 862–872. [ FIND THIS ARTICLE
ONLINE ]
-
Saunders MA, Liang H, Li WH (2007) Human polymorphism
at microRNAs and microRNA target sites,
PNAS 104 (9): 3300–3305.
-
Scholzova E, Malik R, Sevcik J, Kleibl Z (2007) RNA
regulation and cancer development. Cancer Letters
246:12–23. [ FIND THIS ARTICLE
ONLINE ]
-
Smigielski EM, Sirotkin K, Ward M et al (2000) dbSNP:
a database of single nucleotide polymorphisms. Nucleic
Acids Res 28:352–355. [ FIND THIS ARTICLE
ONLINE ]
-
Sonenberg N (1994) mRNA translation: influence of the
5’ and 3’ untranslated regions. Curr Opin Genet Dev
4:310–315. [ FIND THIS ARTICLE
ONLINE ]
-
Stamm S, Ben Ari S, Rafalska I, Tang Y, Zhang Z, etal.
(2005) Function of alternative splicing. Gene 344: 1–20. [ FIND THIS ARTICLE
ONLINE ]
-
Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP,
etal. (2007) Population genomics of human gene expression.
Nat Genet 39:1217–1224. [ FIND THIS ARTICLE
ONLINE ]
-
Wuchty S, Fontana W, Hofacker IL, Schuster P (1999)
Complete suboptimal folding of RNA and the stability of
secondary structures. Biopolymers 49:145–65. [ FIND THIS ARTICLE
ONLINE ]
-
Wu L, Fan J, Belasco JG (2006) MicroRNAs direct rapid
deadenylation of mRNA. Proc. Natl Acad Sci USA 103:
4034-4039. [ FIND THIS ARTICLE
ONLINE ]
-
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, etal. (2006) Unique microRNA molecular
profiles in lung cancer diagnosis and prognosis. Cancer
Cell 9:189–198. [ FIND THIS ARTICLE
ONLINE ]
-
Yang Y, Swaminathan S, Martin BK, Sharan SK (2003)
Aberrant splicing induced by missense mutations in
BRCA1: clues from a humanized mouse model. Hum
Mol Genet 12: 2121–2131. [ FIND THIS ARTICLE
ONLINE ]
-
Zamore PD, Haley B (2005) Ribo-gnome: the big world
of small RNAs. Science 309:1519-1524. [ FIND THIS ARTICLE
ONLINE ]
Top
|
|